| PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ... Cancer discovery 9 (6), 722-737, 2019 | 501 | 2019 |
| Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ... Nature cancer 2 (1), 66-82, 2021 | 144 | 2021 |
| Neurocysticercotic calcifications and hippocampal sclerosis: a case-control study M de Oliveira Taveira, ME Morita, CL Yasuda, AC Coan, R Secolin, ... PloS one 10 (7), e0131180, 2015 | 32 | 2015 |
| Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer M de Oliveira Taveira, S Nabavi, Y Wang, P Tonellato, FJ Esteva, ... Journal of cancer research and clinical oncology 143 (7), 1255-1262, 2017 | 28 | 2017 |
| Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition ML Luo, F Zheng, W Chen, ZM Liang, G Chandramouly, J Tan, NA Willis, ... Cancer research 80 (14), 3033-3045, 2020 | 26 | 2020 |
| Serial-omics of P53−/−, Brca1−/− Mouse Breast Tumor and Normal Mammary Gland SB Breitkopf, M De Oliveira Taveira, M Yuan, GM Wulf, JM Asara Scientific Reports 7 (Article number: 14503 (2017)), doi:10.1038/s41598-017 …, 2017 | 11 | 2017 |
| Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Initial Cancer Staging M Taveira Radiology: Imaging Cancer 3 (2), e219007, 2021 | 9 | 2021 |
| Destruction of a microtubule-bound MYC reservoir during mitosis contributes to vincristine's anticancer activity S Becker, C Kiecke, E Schäfer, U Sinzig, L Deuper, P Trigo-Mourino, ... Molecular Cancer Research 18 (6), 859-872, 2020 | 9 | 2020 |
| Independent validation of CT radiomics models in colorectal liver metastases: Predicting local tumour progression after ablation DJ van der Reijd, C Guerendel, FCR Staal, MP Busard, ... European Radiology, 1-9, 2023 | 2 | 2023 |
| Pulmonary Epithelioid Hemangioendothelioma: Two Case Reports of a Rare Neoplasm with an Unpredictable Prognosis TPF Da Silva, MO Taveira, HO Guzman, MD Guimaraes SN Comprehensive Clinical Medicine 2, 2427-2432, 2020 | 1 | 2020 |
| Pearls and pitfalls of structured staging and reporting of rectal cancer on MRI: an international multireader study N El Khababi, RGH Beets-Tan, L Curvo-Semedo, R Tissier, J Nederend, ... The British Journal of Radiology 96 (1150), 20230091, 2023 | | 2023 |
| Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy M Oliveira Taveira, MJ de Barros e Silva, PN Vieira Barbosa Pinto Immunotherapy 15 (5), 343-351, 2023 | | 2023 |
| Predictive Value of PI-RADS Is Low and Variable. Or Is It? Lessons We Can Learn from BI-RADS M Taveira Radiology: Imaging Cancer 2 (6), e209033, 2020 | | 2020 |
| 860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer A Mehta, E Cheney, C Hartl, C Pantelidou, M Oliwa, J Castrillon, JR Lin, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing … AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, CA Hartl, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 83-83, 2020 | | 2020 |
| Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented … AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, CA Hartl, ... Cancer Immunology Research 8 (3_Supplement), A105-A105, 2020 | | 2020 |
| Abstract P5-04-01: PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be … JL Guerriero, AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, ... Cancer Research 80 (4_Supplement), P5-04-01-P5-04-01, 2020 | | 2020 |
| PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing … JL Guerriero, AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| PARP inhibitor efficacy depends on CD8+ T-cell recruitment via the STING pathway in BRCA-deficient models of triple-negative breast cancer C Pantelidou, O Sonzogni, MDO Taveira, AK Mehta, D Wang, A Kothari, ... Cancer Research 79 (13_Supplement), 4490-4490, 2019 | | 2019 |
| Novel PARP-inhibitor combinations to treat breast cancer. H Hu, MO Taveira, E Theodorou, O Sonzongni, A Juvekar, L Cantley, ... MOLECULAR CANCER RESEARCH 16 (8), 16-17, 2018 | | 2018 |
